Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-28 @ 10:39 AM
Study NCT ID:
NCT03025893
Status:
UNKNOWN
Last Update Posted:
2021-04-19
First Post:
2017-01-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme
Sponsor:
Amsterdam UMC, location VUmc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-01-09
First Submit QC Date:
None
Study First Post Date:
2017-01-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-14
Last Update Post Date:
2021-04-19
Last Update Post Date Type:
ACTUAL